Research, Policy Advances Needed to Fulfill Promise of Genetic Medicine, Experts Say at AAAS

Personalized medicine has been touted as the next revolution in health care, but progress in bringing the right treatment to the right patient at the right time has been limited and will require some policy changes to blossom, according to Dr. Mark B. McClellan, former head of the U.S. Food and Drug Administration.

McClellan spoke at a 20 June conference at AAAS where experts and stakeholders with a wide range of interests discussed both the promise and challenges of translating some of the recent advances in genetics into real-world applications that could benefit patients.

For more information about the AAAS personalized medicine conference, read the full story.